Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kuchimanchi

Showing results (11-20 of 78) with videos related to

Pageof 8
Sort By:
Therapeutic Innovation & Regulatory Science|September 18, 2018
Confounding Issues in Cancer Progress-The Impact of Investor Requirements on Senior Management Compensation and Regulatory Decisions: Tivozanib and Aveo PharmaceuticalsJosephine C Babiarz, Francis Melaragni, Stephen Kerr, et al.
JAAD International|June 22, 2026
Sensitivity of circulating tumor DNA in advanced mycosis fungoides: A retrospective case seriesJennifer DeSimone, Nidhi Kuchimanchi, Jafar Al-Mondhiry, et al.
Journal of the American Academy of Dermatology|March 11, 2026
Ethical considerations surrounding skin-lightening "fairness" creamsNidhi Kuchimanchi, Sriyaa Suresh, Bridget Bryer, et al.
Frontiers in Medicine|May 30, 2024
Case report: Hypertrophic lichen planus initially misdiagnosed as squamous cell carcinomaNidhi Kuchimanchi, Lydia A Luu, Preeya T Shah, et al.
Cancer Reports (Hoboken, N.J.)|July 7, 2025
Immune Checkpoint Inhibitor-Related Dysautonomia in Merkel Cell Carcinoma: A Case ReportNidhi Kuchimanchi, Sai Gajula, Elizabeth M Gaughan, et al.
Journal of the American Academy of Dermatology|June 13, 2025
The Ethics of Teaching Primary Care Physicians to Perform Skin BiopsiesNidhi Kuchimanchi, Gabrielle Schwartzman, Barrett J Zlotoff, et al.
Clinical Pharmacokinetics|November 4, 2019
Population Pharmacokinetics of Blinatumomab in Pediatric and Adult Patients with Hematological MalignanciesJohn David Clements, Min Zhu, Mita Kuchimanchi, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 3, 2020
Phase II Dose Selection for Alpha Synuclein-Targeting Antibody Cinpanemab (BIIB054) Based on Target Protein Binding Levels in the BrainMita Kuchimanchi, Michael Monine, Kumar Kandadi Muralidharan, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 22, 2000
Pharmacokinetics, biliary excretion, and tissue distribution of novel anti-HIV agents, cosalane and dihydrocosalane, in Sprague-Dawley ratsK R Kuchimanchi, C Udata, T P Johnston, et al.
International Journal of STD & AIDS|September 21, 2000
'Get it on' in the millenniumL A Riddell, U Kuchimanchi, J Cope, et al.
Pageof 8

Showing results (11-20 of 78) with videos related to

Sort By:
Pageof 8
Therapeutic Innovation & Regulatory Science|September 18, 2018
Confounding Issues in Cancer Progress-The Impact of Investor Requirements on Senior Management Compensation and Regulatory Decisions: Tivozanib and Aveo PharmaceuticalsJosephine C Babiarz, Francis Melaragni, Stephen Kerr, et al.
JAAD International|June 22, 2026
Sensitivity of circulating tumor DNA in advanced mycosis fungoides: A retrospective case seriesJennifer DeSimone, Nidhi Kuchimanchi, Jafar Al-Mondhiry, et al.
Journal of the American Academy of Dermatology|March 11, 2026
Ethical considerations surrounding skin-lightening "fairness" creamsNidhi Kuchimanchi, Sriyaa Suresh, Bridget Bryer, et al.
Frontiers in Medicine|May 30, 2024
Case report: Hypertrophic lichen planus initially misdiagnosed as squamous cell carcinomaNidhi Kuchimanchi, Lydia A Luu, Preeya T Shah, et al.
Cancer Reports (Hoboken, N.J.)|July 7, 2025
Immune Checkpoint Inhibitor-Related Dysautonomia in Merkel Cell Carcinoma: A Case ReportNidhi Kuchimanchi, Sai Gajula, Elizabeth M Gaughan, et al.
Journal of the American Academy of Dermatology|June 13, 2025
The Ethics of Teaching Primary Care Physicians to Perform Skin BiopsiesNidhi Kuchimanchi, Gabrielle Schwartzman, Barrett J Zlotoff, et al.
Clinical Pharmacokinetics|November 4, 2019
Population Pharmacokinetics of Blinatumomab in Pediatric and Adult Patients with Hematological MalignanciesJohn David Clements, Min Zhu, Mita Kuchimanchi, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 3, 2020
Phase II Dose Selection for Alpha Synuclein-Targeting Antibody Cinpanemab (BIIB054) Based on Target Protein Binding Levels in the BrainMita Kuchimanchi, Michael Monine, Kumar Kandadi Muralidharan, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 22, 2000
Pharmacokinetics, biliary excretion, and tissue distribution of novel anti-HIV agents, cosalane and dihydrocosalane, in Sprague-Dawley ratsK R Kuchimanchi, C Udata, T P Johnston, et al.
International Journal of STD & AIDS|September 21, 2000
'Get it on' in the millenniumL A Riddell, U Kuchimanchi, J Cope, et al.
Pageof 8